Use este identificador para citar ou linkar para este item:
https://ri.ufs.br/jspui/handle/riufs/24168Registro completo de metadados
| Campo DC | Valor | Idioma |
|---|---|---|
| dc.contributor.author | Calvo, Ana Cristina | - |
| dc.contributor.author | Manzano, Raquel | - |
| dc.contributor.author | Mendonça, Deise Maria Furtado de | - |
| dc.contributor.author | Muñoz, María J. | - |
| dc.contributor.author | Zaragoza, Pilar | - |
| dc.contributor.author | Osta, Rosario | - |
| dc.date.accessioned | 2026-01-09T16:48:53Z | - |
| dc.date.available | 2026-01-09T16:48:53Z | - |
| dc.date.issued | 2014 | - |
| dc.identifier.citation | CALVO, A. C. et al. Amyotrophic lateral sclerosis: a focus on disease progression. BioMed Research International, New York, n. 1, 2014. Disponível em: https://onlinelibrary.wiley.com/doi/epdf/10.1155/2014/925101. Acesso em: 9 jan. 2026. | pt_BR |
| dc.identifier.issn | 2314-6141 | - |
| dc.identifier.uri | https://ri.ufs.br/jspui/handle/riufs/24168 | - |
| dc.language | eng | pt_BR |
| dc.publisher | Hindawi Publishing Corporation | pt_BR |
| dc.relation.ispartof | BioMed Research International | pt_BR |
| dc.subject | Amyotrophic lateral sclerosis | eng |
| dc.subject | Neurodegenerative diseases | eng |
| dc.subject | Disease progression | eng |
| dc.subject | Therapeutic strategies | eng |
| dc.title | Amyotrophic lateral sclerosis: a focus on disease progression | pt_BR |
| dc.type | Artigo | pt_BR |
| dc.identifier.license | Creative Commons Atribuição 3.0 Não Adaptada (CC BY 3.0) | pt_BR |
| dc.description.resumo | Since amyotrophic lateral sclerosis (ALS) was discovered and described in 1869 as a neurodegenerative disease in which motorneuron death is induced, a wide range of biomarkers have been selected to identify therapeutic targets. ALS shares altered molecular pathways with other neurodegenerative diseases, such as Alzheimer’s, Huntington’s, and Parkinson’s diseases. However,the molecular targets that directly influence its aggressive nature remain unknown. What is the first link in the neurodegenerativechain of ALS that makes this disease so peculiar? In this review, we will discuss the progression of the disease from the viewpointof the potential biomarkers described to date in human and animal model samples. Finally, we will consider potential therapeuticstrategies for ALS treatment and future, innovative perspectives. | pt_BR |
| dc.description.local | New York | pt_BR |
| Aparece nas coleções: | DBCI - Artigos de periódicos | |
Arquivos associados a este item:
| Arquivo | Descrição | Tamanho | Formato | |
|---|---|---|---|---|
| AmyotrophicLateralSclerosisDiseaseProgression.pdf | 376,06 kB | Adobe PDF | ![]() Visualizar/Abrir |
Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.
